MelliCell Inc.

About MelliCell Inc.

MelliCell is a biotechnology company focused on pioneering next-generation therapeutics for chronic diseases using innovative fat cell engineering technology. They aim to redefine how fat cells are studied and targeted in conditions like obesity, diabetes, and cancer, with a mission to improve human health through scientific excellence and collaborative innovation.

Products & Services

Fat-Targeted Therapeutics:Therapeutics designed to target fat cells for treating obesity and associated chronic diseases using proprietary M3 technology.

Therapeutic Adipokines:Development of adipokines as therapeutic agents for chronic diseases.

Surgical and Tissue Engineering Substrates:Fat cell-based substrates for surgical and tissue engineering applications.

Specialties

Fat Cell Engineering Chronic Disease Therapeutics Obesity Treatment Metabolic Dysfunction Adipocyte Biology M3 Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Grant T: - FT: SBIR Grant	A: 275000 MR: - FA: $275,000 FAN: 275000	D: 2024-03-28 FD: 2024-03-28	1 investors

SBIR Grant Latest

2024-03-28

$275K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

Davide Ruggero

Professor of Urology and Cellular & Molecular Pharmacology at the University of California, San Francisco

B

Ben Pope

CEO

D

Dr. Madhumita Basu

Principal Scientist, Target Discovery

LinkedIn (Pro only)

D

Dr. Perry Bickel

Scientific Advisory Board

D

Dr. Benjamin T. Bikman

Associate Professor of Physiology and Developmental Biology

D

Dr. Aaron Glieberman

Director, Platform Development

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

MelliCell Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised